CD44 and malignant colon neoplasm: Moreover, another in vivo study has demonstrated the mechanisms of the SPP1 – CD44 axis in colon cancer in a mouse model, that the osteopontin acts as an immune checkpoint to suppress T cell activation and promotes tumor immune evasion in colon carcinoma (80).